F
Francisco Beca
Researcher at Stanford University
Publications - 39
Citations - 3526
Francisco Beca is an academic researcher from Stanford University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 16, co-authored 38 publications receiving 2399 citations. Previous affiliations of Francisco Beca include Beth Israel Deaconess Medical Center & University of Porto.
Papers
More filters
Journal ArticleDOI
Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer.
Babak Ehteshami Bejnordi,Mitko Veta,Paul J. van Diest,Bram van Ginneken,Nico Karssemeijer,Geert Litjens,Jeroen van der Laak,Meyke Hermsen,Quirine F. Manson,Maschenka Balkenhol,Oscar Geessink,N. Stathonikos,Marcory C. R. F. van Dijk,Peter Bult,Francisco Beca,Andrew H. Beck,Dayong Wang,Aditya Khosla,Rishab Gargeya,Humayun Irshad,Aoxiao Zhong,Qi Dou,Qi Dou,Quanzheng Li,Hao Chen,Huangjing Lin,Pheng-Ann Heng,Christian Haß,Elia Bruni,Quincy Wong,Ugur Halici,Mustafa Umit Oner,Rengul Cetin-Atalay,Matt Berseth,Vitali Khvatkov,Alexei Vylegzhanin,Oren Kraus,Muhammad Shaban,Nasir M. Rajpoot,Nasir M. Rajpoot,Ruqayya Awan,Korsuk Sirinukunwattana,Talha Qaiser,Yee-Wah Tsang,David Tellez,Jonas Annuscheit,Peter Hufnagl,Mira Valkonen,Kimmo Kartasalo,Kimmo Kartasalo,Leena Latonen,Pekka Ruusuvuori,Pekka Ruusuvuori,Kaisa Liimatainen,Shadi Albarqouni,Bharti Mungal,Ami George,Stefanie Demirci,Nassir Navab,Seiryo Watanabe,Shigeto Seno,Yoichi Takenaka,Hideo Matsuda,Hady Ahmady Phoulady,Vassili Kovalev,A. Kalinovsky,Vitali Liauchuk,Gloria Bueno,M. Milagro Fernández-Carrobles,Ismael Serrano,Oscar Deniz,Daniel Racoceanu,Daniel Racoceanu,Rui Venâncio +73 more
TL;DR: In the setting of a challenge competition, some deep learning algorithms achieved better diagnostic performance than a panel of 11 pathologists participating in a simulation exercise designed to mimic routine pathology workflow; algorithm performance was comparable with an expert pathologist interpreting whole-slide images without time constraints.
Journal ArticleDOI
Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.
Xiangpeng Dai,Wenjian Gan,Xiaoning Li,Xiaoning Li,Shangqian Wang,Wei Zhang,Ling Huang,Shengwu Liu,Qing Zhong,Jianping Guo,Jinfang Zhang,Ting Chen,Kouhei Shimizu,Francisco Beca,Mirjam Blattner,Divya Vasudevan,Dennis L. Buckley,Jun Qi,Lorenz Buser,Pengda Liu,Hiroyuki Inuzuka,Andrew H. Beck,Liewei Wang,Peter J. Wild,Levi A. Garraway,Mark A. Rubin,Christopher E. Barbieri,Kwok-Kin Wong,Senthil K. Muthuswamy,Jiaoti Huang,Yu Chen,James E. Bradner,Wenyi Wei +32 more
TL;DR: The results elucidate the tumor-suppressor role of SPOP in prostate cancer in which it acts as a negative regulator of BET protein stability and also provide a molecular mechanism for resistance to BET inhibitors in individuals with prostate cancer bearing SPOP mutations.
Journal ArticleDOI
Predicting breast tumor proliferation from whole-slide images: The TUPAC16 challenge.
Mitko Veta,Yujing J. Heng,Nikolas Stathonikos,Babak Ehteshami Bejnordi,Francisco Beca,Thomas Wollmann,Karl Rohr,Manan Shah,Dayong Wang,Mikael Rousson,Martin Hedlund,David Tellez,Francesco Ciompi,Erwan Zerhouni,David Lanyi,Matheus P. Viana,Vassili Kovalev,Vitali Liauchuk,Hady Ahmady Phoulady,Talha Qaiser,Simon Graham,Nasir M. Rajpoot,Erik Sjöblom,Jesper Molin,Kyunghyun Paeng,Sangheum Hwang,Sunggyun Park,Zhipeng Jia,Eric Chang,Yan Xu,Andrew H. Beck,Paul J. van Diest,Josien P. W. Pluim +32 more
TL;DR: The achieved results are promising given the difficulty of the tasks and weakly‐labeled nature of the ground truth, however, further research is needed to improve the practical utility of image analysis methods for this task.
Journal ArticleDOI
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.
Carlos R. Gil Del Alcazar,Sung Jin Huh,Muhammad B. Ekram,Anne Trinh,Lin Liu,Francisco Beca,Francisco Beca,Xiaoyuan Zi,Xiaoyuan Zi,Minsuk Kwak,Helga Bergholtz,Ying Su,Ying Su,Lina Ding,Hege G. Russnes,Andrea L. Richardson,Andrea L. Richardson,Kirsten Babski,Elizabeth Min Hui Kim,Charles H. McDonnell,Jon Wagner,Ron Rowberry,Gordon J. Freeman,Deborah A. Dillon,Therese Sørlie,Lisa M. Coussens,Judy Garber,Rong Fan,Kristie Bobolis,D. Craig Allred,Joon Jeong,So Yeon Park,Franziska Michor,Kornelia Polyak,Kornelia Polyak +34 more
TL;DR: A switch to a less active tumor immune environment during the in situ to invasive breast carcinoma transition is demonstrated, and immune regulators and genomic alterations that shape tumor evolution are identified.
Journal ArticleDOI
Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types
Francisco Beca,Pedro Caetano,Renê Gerhard,César Augusto Alvarenga,Madalena Gomes,Joana Paredes,Fernando Schmitt +6 more
TL;DR: The expression distribution of breast CSC markers is largely dependent on histological type, and within the distinct SHT, medullary and metaplastic carcinomas are the two types highly associated with high-grade carcinomas, basal-like and claudin-low molecular subtypes, and to the CSC phenotype CD44+/CD24−/low/ALDH1+.